/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

F

Francesco Marampon

Policlinico Umberto I(IT)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

242

Papers

4.6K

Citations

39

h-index

109

i10-index

Francesco Marampon is an academic researcher from Policlinico Umberto I. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Glioma Diagnosis and Treatment & Prostate Cancer Treatment and Research. The author has an h-index of 39, co-authored 206 publications.

ORCID: 0000-0002-0588-3039

Research Topics

Sarcoma Diagnosis and Treatment Glioma Diagnosis and Treatment Prostate Cancer Treatment and Research Histone Deacetylase Inhibitors Research Melanoma and MAPK Pathways

Papers by this author

works

Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation

2010 · Molecular Cancer · 136 citations

https://doi.org/10.1186/1476-4598-9-305

Giovanni Luca Gravina Claudio Festuccia Francesco Marampon Vladimir M. Popov

A feasibility study of percutaneous radiofrequency ablation followed by radiotherapy in the management of painful osteolytic bone metastases

2011 · European Radiology · 96 citations

https://doi.org/10.1007/s00330-011-2133-3

Mario Di Staso Luigi Zugaro Giovanni Luca Gravina Pierluigi Bonfili

Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population

2016 · Molecular Cancer · 82 citations

https://doi.org/10.1186/s12943-016-0501-y

Carmela Ciccarelli Francesca Vulcano Luisa Milazzo Giovanni Luca Gravina

p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells

2005 · Molecular Cancer · 76 citations

https://doi.org/10.1186/1476-4598-4-41

Carmela Ciccarelli Francesco Marampon Arianna Scoglio Annunziata Mauro

The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma

2017 · Journal of Hematology & Oncology · 70 citations

https://doi.org/10.1186/s13045-016-0377-8

Giovanni Luca Gravina A. Mancini Francesco Marampon Alessandro Colapietro

KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models

2015 · BMC Cancer · 61 citations

https://doi.org/10.1186/s12885-015-1936-z

Giovanni Luca Gravina Andrea Mancini Patrizia Sanità Flora Vitale

Research topics

topics

Sarcoma Diagnosis and Treatment

Glioma Diagnosis and Treatment

Prostate Cancer Treatment and Research

Histone Deacetylase Inhibitors Research

Melanoma and MAPK Pathways

Chat about Author

Papers

Chat

Click to start Chat